Technetium-99m-EC and other potential new agents in renal nuclear medicine

Seminars in Nuclear Medicine

Volumn 29, Issue 2, 1999, Pages 91-101

  Moran, J K ^a  

^a Department of Nuclear Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE ETHYL ESTER TC 99M; IODOHIPPURIC ACID; MERTIATIDE TC 99M; TECHNETIUM 99M; TECHNETIUM COMPLEX;

ARTICLE; CLINICAL TRIAL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG TRANSPORT; HUMAN; IMAGE QUALITY; KIDNEY DISEASE; KIDNEY PLASMA FLOW; KIDNEY SCINTISCANNING; KIDNEY TRANSPLANTATION; NONHUMAN; PLASMA PROTEIN BINDING; RENOVASCULAR HYPERTENSION; URINARY EXCRETION;

EID: 0033010627     PISSN: 00012998     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-2998(99)80002-6     Document Type: Article

References (38)

1. 131labelled sodium iodohippurate in kidney function test Proc Soc Exp Biol Med 63 1960 497 498
2. Fritzberg AR Kuni CC Klingensmith WC III Synthesis and biological evaluation of Tc-99m-N,N-bis(mercaptoacetyl)-2,3-diaminopropanoate: A potential replacement for (I-131)o-iodohippurate J Nucl Med 23 1982 592 598
3. Chervu LR Sandro BM Blaufox MD Technetium-99m labeled p-aminohippuic acid analog: A new renal agent J Nucl Med 25 1984 1111 1115
4. 3 as a hippuran replacement J Nucl Med 27 1986 111 116
5. 99mTc-ECD and their metabolites in mice Nicolini M Bandoli G Mazziu Technetium and Rhenium in Chemistry and Nuclear Medicine 3 1990 Cortica International Verona 445 452
6. Verbruggen A Nosco DL Van Nerom CG Technetium-99m-L,L-ethylenedicysteine: a renal imaging agent. I labeling and evaluation in animals J Nucl Med 33 1992 551 557
7. Despopoulos A A definition of substrate specificity in renal transport of organic anions J Theor Biol 8 1965 163 192
8. 2 Inorg Chem 34 1995 3579 3580
9. Taylor A Jr Hansen L Eshima D Comparison of technetium-99m-LL-EC isomers in rats and humans J Nucl Med 38 1997 821 826
10. m-biscisate as a renal imaging agent Nucl Med Commun 18 1997 771 775
11. Van Nerom CG Bormans GM DeRoo MJ First experience in healthy volunteers with technetium-99m-L,L-ethylenedicysteine a new renal imaging agent Eur J Nucl Med 20 1993 738 746
12. Ozker D Onsel C Kabasakal L Technetium-99m-N,N-ethylenedicysteine a comparative study of renal scintigraphy with technetium-99m-MAG3 and Iodine-131-OIH in patients with obstructive renal disease J Nucl Med 35 1994 840 845
13. m-MAG3 Nucl Med Commun 18 1997 44 52
14. Gupta NK Bomanji JB Waddington W Technetium-99m-L,L-ethylenedicysteine scintigraphy in patients with renal disease Eur J Nucl Med 22 1995 617 624
15. Stoffel M Jamar F Van Nerom CG Evaluation of technetium-99m-L,L-EC in renal transplant recipients: A comparative study with technetium-99m-MAG3 and iodine-125-OIH J Nucl Med 35 1994 1951 1958
16. 99mTc-EC captopril test in patients with hypertension Nucl Med Commun 16 1995 128 131
17. 99mTc-ethylenedicysteine captopril scintigraphy Invest Radiol 31 1996 497 501
18. Ugur O Peksoy I Caner B Technetium-99m-ethylenedicysteine: An alternative agent to detect renovascular hypertension J Nucl Med 38 1997 1662 1664
19. Ugur O Peksoy I Caner B Results of a 2 year prospective study to assess efficacy and methodology of technetium-99m-EC captopril scintigraphy [abstract] Eur J Nucl Med 24 1997 940
20. Eshima D Taylor A Jr Fritzberg AR Animal evaluation of Tc-99m triamide mercaptide complexes as potential renal imaging agents J Nucl Med 28 1987 1180 1186
21. Eshima D Fritzberg AR Taylor A Jr Biological studies on a new class of Tc-99m renal tubular function agents Billingburst MW Current Applications in Radiopharmacology Proceeding of the Fourth International Symposium on Radiopharmacology 1986 Pergamam Elmsford, NY 237 247
22. 99mTc renal tubular function agents: Current status Semin Nucl Med 20 1990 28 40
23. 3 Eur J Nucl Med 24 1997 1374 1379
24. Johannsen B Syhre R Spies H Chemical and biological characterisation of different Tc-complexes of cysteine and cystine derivatives J Nucl Med 19 1978 816 824
25. m-glucoheptonate to evaluate its functional and imaging characteristics Nucl Med Commun 15 1994 878 885
26. Misra M Das BK Gambhir S Clinical evaluation of Tc-99m cystine a new renal radiopharmaceutical Clin Nucl Med 19 1994 314 320
27. 99mTc-2GAM: A tracer for renal imaging Nucl Med Biol 23 1996 927 933
28. Preuss HG Massry SG Maher JF Effects of uremic sera on renal tubular p-aminohippurate transport Nephron 3 1966 265 273
29. Herzog KM Deutsch E Deutsch K Synthesis and renal excretion of technetium-99m-labeled organic cations J Nucl Med 33 1992 2190 2195
30. Solanki KK Britton KE Bomanji J Tc-99m labelled cationic complexes—A new class of renal imaging agents—results of preliminary human studies [abstract] J Nucl Med 32 1991 1105
31. 99mTc-diaminocyclohexane a renal tubular agent with cationic transport: Results in healthy human volunteers Nephron 65 1993 294 298
32. Kabasakal L Turogla HT Onsel C Clinical comparison of technetium-99m-EC, technetium-99m-MAG3 and iodine-131-OIH in renal disorders J Nucl Med 34 1995 224 228
33. Prvulovich EM Bomanji JB Waddington WA Clinical evaluation of technetium-99m-L,L-ethylenedicysteine in patients with chronic renal failure J Nucl Med 28 1997 809 814
34. Kabasakal L Atay S Vural VA Evaluation of technetium-99m-ethylenedicysteine in renal disorders and determination of extraction ratio J Nucl Med 36 1995 1398 1403
35. Atlas SA Laragh JH Atrial natriuretic peptide: a new factor in hormonal control of blood pressure and electrolyte homeostasis Ann Rev Med 37 1986 397 414
36. Lambert R Willenbrock R Tremblay J Receptor imaging with Atrial natriuretic peptide part 1: high specific activity iodine-123-atrial natriuretic peptide J Nucl Med 35 1994 628 637
37. 111In labelled antilymphocyte and anti-class I and II major histocompatibility complex monoclonal antibodies Tranplantation Proc 23 1991 2143 2146
38. Chen F Wisner JR Omachi H Localization of monoclonal antibody TNT-1 in experimental kidney inforction of the mouse FASEB 4 1990 3033 3039